MicroRNAs regulated by lipopolysaccharide (LPS) target genes that contribute to the inflammatory phenotype. Here, we showed that the protein kinase Akt1, which is activated by LPS, positively regulated miRNAs let-7e and miR-181c but negatively regulated miR-155 and miR-125b. In silico analyses and transfection studies revealed that let-7e repressed Toll-like receptor 4 (TLR4), whereas miR-155 repressed SOCS1, two proteins critical for LPS-driven TLR signaling, which regulate endotoxin sensitivity and tolerance. As a result, Akt1 À/À macrophages exhibited increased responsiveness to LPS in culture and Akt1 À/À mice did not develop endotoxin tolerance in vivo. Overexpression of let-7e and suppression of miR-155 in Akt1 À/À macrophages restored sensitivity and tolerance to LPS in culture and in animals. These results indicate that Akt1 regulates the response of macrophages to LPS by controlling miRNA expression.
INTRODUCTION
Activation of macrophages by lipopolysaccharide (LPS) initiates feedback inhibitory loops that aim in establishing tolerance to a subsequent LPS stimulus. Negative feedback signals either inhibit the expression of genes that are required for the response to LPS, such as the LPS receptor Toll-like receptor 4 (TLR4), or promote the expression of genes that inhibit the response, such as suppressor of cytokine signaling 1 (SOCS1) and IL-1 receptor-associated kinase-M (IRAK-M). Thus, within a few hours from the start of LPS stimulation, the expression of the LPS receptor TLR4 decreases, to rise again 24 to 48 hr later (Medvedev et al., 2000; Nomura et al., 2000) . Negative regulators of TLR4 signaling such as SOCS1 (Kinjyo et al., 2002; Nakagawa et al., 2002) and IRAK-M (Kobayashi et al., 2002) are upregulated within 2 hr from the start of the stimulation. The net effect of the downregulation of TLR4 and the induction of negative regulatory molecules is the emergence of tolerance to LPS restimulation. Mutations that interfere with these negative regulatory loops promote hyperresponsiveness to LPS and inhibit the development of endotoxin tolerance (Kinjyo et al., 2002; Nakagawa et al., 2002; Kobayashi et al., 2002) . One pathway that plays a critical role in feedback inhibition of LPS signals is the phosphoinositide-3 kinase (PI-3K)-Akt kinase signaling pathway (Fukao and Koyasu, 2003; Guha and Mackman, 2002; Luyendyk et al., 2008; Williams et al., 2006; Zhang et al., 2007) .
Akt (also known as PKB) is a family of serine-threonine protein kinases that are activated by PI-3K and that play key regulatory roles in a host of cellular functions including cell survival, cell proliferation, differentiation, and intermediary metabolism. Stimulation of macrophages with the TLR4 agonist LPS activates PI-3K and its downstream targets, including Akt kinases. Thus, activation of the PI-3K-Akt pathway suppresses LPS-activated MAPK and NF-kB signaling cascades in monocytes and dendritic cells, resulting in decreased production of TNF-a and other cytokines (Fukao et al., 2002; Guha and Mackman, 2002) . Moreover, inhibition of Glucogen Synthase Kinase-3 (GSK3) in vivo, a kinase that is phosphorylated and inactivated by Akt, results in resistance to endotoxin shock (Martin et al., 2005) , suggesting that inhibition of Akt will render mice more sensitive to LPS. Consistent with these observations, Akt overexpression in lymphocytes prevents sepsis-induced apoptosis and improves survival in a cecal ligation and puncture (CLP) model of polymicrobial sepsis (Bommhardt et al., 2004) . Moreover, whereas macrophages deficient of the p85a subunit of PI-3K are hyperresponsive, macrophages deficient of PTEN, a phosphatase that antagonizes PI-3K, are hyporesponsive to signals associated with macrophage activation (Luyendyk et al., 2008) .
MicroRNAs (miRNAs) play a central role in gene expression. Mechanistically, miRNAs pair with partially complementary sequences in target mRNAs and regulate their stability and/or translation. Changes in the expression of miRNAs during the response to extracellular signals, or during differentiation or oncogenic transformation, allow miRNAs to regulate these processes. Recent studies have identified miRNAs as critical regulators of immune responses including inflammation (Baltimore et al., 2008; Chong et al., 2008; Cobb et al., 2006; Liston et al., 2008; Lu et al., 2009; Xiao and Rajewsky, 2009; Zhou et al., 2008) . In addition, LPS stimulation upregulates or represses the expression of miRNAs in macrophages. Among the LPS-responsive miRNAs characterized to date, miR-155 is upregulated in response to LPS (O'Connell et al., 2007; Tili et al., 2007) , promoting the expression of TNF-a and destabilization of PU.1 (Vigorito et al., 2007) , a key mediator of monocyte and macrophage differentiation and TLR4 transcription (Roger et al., 2005; Tsatsanis et al., 2006; Vigorito et al., 2007) . MiR-155 also targets and suppresses SOCS1, a critical regulator of STAT signaling, in regulatory T cells (Lu et al., 2009 ) and the inositol phosphatase SHIP1 (O'Connell et al., 2009) . In contrast, miR-125b inhibits the expression of TNF-a and is downregulated in LPS-treated macrophages .
Given the importance of Akt in the negative feedback of TLR4 signaling, we examined the role of Akt1, one of the three Akt isoforms, in miRNA expression in LPS-activated macrophages. In mammals, the Akt family consists of three isoforms, Akt1 (PKBa), Akt2 (PKBb), and Akt3 (PKBg), which are functionally distinct despite their sequence similarities (Cho et al., 2001; Easton et al., 2005; Mao et al., 2007; Maroulakou et al., 2007; Yang et al., 2005) . Recent studies showed that Akt1 ablation in mice gives rise to a proinflammatory phenotype resulting in enhanced atherogenesis (Fernandez-Hernando et al., 2007) .
Here, we examined the role of Akt1 in the regulation of miRNA expression in LPS-stimulated macrophages. miRNA arrays revealed that LPS-treated Akt1 À/À macrophages failed to induce let-7e and expressed higher amounts of miR-155, in contrast to Akt1 +/+ macrophages. In silico analysis and transfection studies revealed that let-7e controlled TLR4 and miR-155 SOCS1 and that these miRNAs were under the control of Akt1. As a result, Akt1 À/À macrophages were hyperresponsive to LPS and failed to develop endotoxin tolerance in culture and in vivo. Introduction of these miRNAs in Akt1 À/À macrophages restored their response to LPS, indicating that Akt1 controls macrophage responsiveness to LPS endotoxin tolerance by regulating the expression of miRNAs.
RESULTS

Akt1
Regulates LPS-Induced miRNA Expression in Macrophages LPS-generated signals in macrophages regulate miRNAs that control the expression of molecules involved in TLR signaling (O'Connell et al., 2007; Tili et al., 2007) . Because LPS signals activate Akt, we questioned whether Akt1 ablation affects the expression of microRNAs that regulate TLR signals in unstimulated and LPS-stimulated macrophages. miRNA expression was analyzed with an array containing 365 miRNAs, as described in the Experimental Procedures. Figure 1A depicts miRNAs, the expression of which was affected in the presence or absence of LPS and Akt1, in thioglycollate-induced primary macrophages from Akt1 +/+ and Akt1 À/À mice. The results were confirmed by real-time RT-PCR and showed that LPS promoted the expression of let-7e and miR-181c in Akt1 +/+ cells only.
In addition, LPS upregulated miR-155 and downregulated miR-125b, and in the absence of Akt1, LPS failed to suppress miR-125b. In contrast, the induction of miR-155 was more pronounced in the absence of Akt1 ( Figure 1B ). In unstimulated Akt1 À/À macrophages, let-7e was expressed at greater amounts. However, the induction of let-7e by LPS was abrogated in the absence of Akt1 ( Figure 1B) . Expression of let-7e and miR-155 in Akt1 +/+ cells was induced after 3 hr of LPS treatment and remained high at 24 hr after stimulation (data not shown). LPS did not induce let-7e even at 24 hr from the start of stimulation in Akt1 À/À macrophages (data not shown). miRNAs can be regulated at the transcriptional or posttranscriptional level. Transcriptional activation of the miRNA locus results in generation of the pri-miRNA, which is subsequently processed to give rise to pre-miRNA and then to the mature miRNA. To determine whether Akt1 affects let-7e, miR-155, miR-181c, and miR-125b at the transcriptional or posttranscriptional level, we measured expression of pri-let-7e, pri-miR-155, pri-miR-181c, and pri-miR-125b in LPS-stimulated Akt1 +/+ and Akt1 À/À macrophages. The results showed that LPS increased the expression of pri-let-7e, pri-miR-155, and pri-miR-181c, whereas it suppressed pri-miR-125b. Ablation of Akt1 resulted in reduced pri-let-7e and pri-miR-181c, increased pri-miR-155 and abolished the suppression of pri-miR-125b ( Figure 1C ). We could, therefore, conclude that Akt1 regulates these miRNAs at the level of transcription. To confirm that Akt1 controls the expression of let-7e, miR-155, miR-181c and miR-125b, we infected primary bone marrow-derived macrophages (BMDMs) with a retrovirus expressing myristoylated Akt1 (myrAkt1), a constitutively active mutant of Akt1, and GFP under independent promoters, to determine infection efficiency. Almost all cells expressed GFP 72 hr after infection (data not shown). RNA was isolated and the expression of let-7e, miR-155, miR-181c and miR-125b was determined. Active Akt1 induced the basal expression of let-7e and mir-181c and suppressed the basal expression of miR-155, whereas it had no effect on the basal expression of miR125b ( Figure 1D ). In LPS-stimulated cells, expression of myrAkt1 resulted in augmented let-7e and miR-181c expression, augmented suppression of miR-125b, and reduced induction of miR-155 ( Figure 1D ), confirming that these miRNAs are under the control of Akt1. The same results were observed in the Raw264.7 macrophage cell line when infected with a myr-Akt-GFP retrovirus (data not shown) or transiently transfected with a myr-Akt1-GFP plasmid, and GFP-positive cells were sorted by flow cytometry and collected for further analysis (data not shown).
To identify potential targets for these miRNAs, we screened their sequences against the mouse genome database, by using the miRNA target identification programs miRBase, PicTar, and TargetScan v.4.0, as described in the Experimental Procedures. This analysis identified TLR4 as a potential let-7e target, TNF-a as potential target of miR-125b, and TNFSF11 (also known as RANKL) as a potential target of miR-181c ( Figure 1E ). In addition to known miR-155 targets, IKK3, TRAF6, and RIPK , this analysis identified SOCS1 as a potential miR-155 target ( Figure S1 ). Our findings were consistent with previously published data showing that the let-7e isoform let-7i targets and promotes degradation of TLR4 mRNA in human cholangiocytes (Chen et al., 2007) and that miR-155 targets and suppresses SOCS1 in mouse regulatory T cells (Lu et al., 2009 ).
Mediates LPS-Induced TLR4 and SOCS1 Regulation TLR4 and SOCS1 are key regulators of macrophage sensitivity to LPS, and their expression affects the magnitude of the response and, therefore, the amounts of proinflammatory mediators. Because Akt1 affects let-7e and miR-155 and our predictions suggest that let-7e targets TLR4 and miR-155 targets SOCS1, we examined whether TLR4 and SOCS1 are regulated by Akt1.
We tested whether Akt1 ablation affects TLR4 and SOCS1 expression. If the expression of TLR4 in macrophages is suppressed by let-7e, one would expect that LPS stimulation would downregulate TLR4 in wild-type but not in Akt1 À/À macrophages. In addition, the expression of TLR4 in unstimulated Similarly, if the expression of SOCS1 in macrophages is suppressed by miR-155, one would expect that LPS stimulation would upregulate the expression of SOCS1 more efficiently in wild-type than in Akt1 À/À macrophages because LPS-treated
À/À cells expressed more miR-155 than Akt1 +/+ cells. It is important to note that SOCS1 expression is induced by LPS and is elevated, despite its role in negative regulation of LPS responsiveness. In this case, miR-155 modulates the amount of SOCS1 induction. Immunoblot and real-time RT-PCR analysis revealed that LPS-treated Akt1 À/À macrophages expressed lower amounts of SOCS1 compared to their wild-type counterparts (Figures 2D and 2E) , suggesting that Akt1, via suppression of miR-155, augments SOCS1 expression. To confirm that TLR4 and SOCS1 are regulated by Akt1, we determined their expression in primary BMDMs infected with a retrovirus expressing myrAkt1 and GFP, as described in Figure 1C and in the Experimental Procedures. Cells were analyzed for expression of TLR4 and SOCS1. The results indicated that myrAkt1 suppressed basal TLR4 expression ( Figure 3A ) and further augmented LPS-induced TLR4 suppression ( Figures 3B  and 3C ). In addition, myrAkt1 augmented LPS-induced SOCS1 protein and mRNA expression ( Figures 3D and 3E ). The same results were obtained in Raw264.7 macrophages infected with a retrovirus expressing myr-Akt1 or after transient transfection of myrAkt1 (data not shown). Thus, these results support our observation that Akt1 suppresses LPS-induced miR-155 ( Figure 1D ), resulting in increased LPS-induced SOCS1 ( Figures  3D and 3E ).
Let-7e Targets TLR4 and miR-155 Targets SOCS1 Because Akt1 controls the expression of let-7e, miR-155, and their predicted targets TLR4 and SOCS1, respectively, we wanted to confirm that TLR4 and SOCS1 are indeed regulated by these miRNAs. On the basis of the sequence alignment of let-7e with TLR4 mRNA (Figure S2A ), the miRNA programs mentioned above predicted that TLR4 is a likely target of let-7e. To validate the finding that let-7e suppresses TLR4, we transfected RAW264.7 macrophages with let-7e or with its antisense counterpart as-let7e. Control cells were transfected with scrambled miRNA (SCR-miRNA). Real-time RT-PCR with total-cell RNA harvested at the indicated time points revealed that whereas let-7e inhibited, as-let-7e enhanced the expression of TLR4 ( Figures 4A and 4B ). Let-7e was effectively suppressed by as-let-7 within 12 hr after transfection ( Figure S3 ). To confirm the in silico prediction that let7e interacted with the 3 0 UTR of TLR4, we cloned 383 bp of the 3 0 UTR of TLR4 that included the let-7e-binding site downstream of the luciferase gene (TLR4-UTR-luc) and cotransfected them with let-7e or its antisense inhibitor as-let-7e in Raw264.7 macrophages. The results indicated that let-7e suppressed whereas as-let-7e enhanced luciferase expression and activity, thereby showing a direct interaction between let-7e and the 3 0 UTR of TLR4 ( Figure 4C ). Mutation at the seed sequence of the TLR4-3 0 UTR where let-7e was predicted to bind (mutTLR4-UTR-luc) abolished suppression by let-7e ( Figure 4C ).
Sequence alignment of miR-155 with SOCS1 mRNA predicted that SOCS1 is a likely target of miR-155 ( Figure S2B ). Earlier studies indicated that miR-155 and SOCS1 interacted in regulatory T cells and in 293T cells (Lu et al., 2009) . To confirm that miR-155 also regulates SOCS1 in macrophages, we transfected RAW264.7 macrophages with as-miR-155 or SCR-miRNA. Realtime RT-PCR with total-cell RNA harvested at the indicated time points revealed that as-miR-155 enhanced the expression of SOCS1 both in naive ( Figure 4D ) and LPS-activated ( Figure 4E ) RAW264.7 cells. miR-155 was effectively suppressed by asmiR-155 within 24 hr after transfection ( Figure S4 ). To confirm that miR-155 interacted with the 3 0 UTR of SOCS1, we cloned a 397 bp fragment of the SOCS1 3 0 UTR that contained the miR-155-binding site downstream the luciferase gene (SOCS1-UTR-luc) and cotransfected it with miR-155 or as-miR-155 in Raw264.7 macrophages. The results indicated that miR-155 suppressed whereas as-miR-155 enhanced luciferase expression and activity and that mutation of the seed sequence for miR-155 at the 3 0 UTR of SOCS1 (mutSOCS1-UTR-luc) abolished the suppression ( Figure 4F ). Thus, these results support the in silico prediction that let-7e and miR-155 directly targeted the 3 0 UTR of TLR4 and SOCS1, respectively.
Let-7e, miR-155, and Akt1 Regulate Endotoxin Sensitivity and Tolerance To determine whether differential expression of the microRNAs let-7e and miR-155 affects the magnitude of macrophage response to LPS, we transfected Raw264.7 macrophages with as-let-7e, let-7e, miR-155, as-miR-155, or combinations of these prior to LPS stimulation, measured the proinflammatory mediators TNF-a, IL-6, IL-17, IP-10, MCP-1, MIP-1a, and PGE2, and compared them to SCR-miRNA-transfected cells. Efficacy of let-7e and miR-155 suppression by as-let-7e and as-miR-155 was evaluated by real-time RT-PCR (data not shown). The results showed that introduction of as-let-7e augmented whereas let-7e suppressed the response to LPS.
In contrast, introduction of as-miR-155 suppressed whereas miR-155 augmented the LPS response. Combination of aslet-7e and miR-155 exhibited the highest increase in proinflammatory mediators, whereas combination of let-7e and as-miR-155 significantly reduced all proinflammatory mediators ( Figure 5A ). The preceding data suggest that differential expression of let7e, miR-155, and their target genes TLR4 and SOCS1 may contribute to enhanced induction of proinflammatory cytokines by LPS in Akt1 À/À compared to Akt1 +/+ macrophages. Stimulation of Akt1 +/+ and Akt1 À/À thioglycollate-elicited peritoneal macrophages with LPS for 24 hr resulted in increased expression of proinflammatory mediators. However, ablation of Akt1 resulted in increased secretion of the proinflammatory cytokines TNF-a, IL-6, and IL-17 and the proinflammatory chemokines IP-10, MIP-1a, and MCP-1, and also increased production of Raw264.7 cells were transfected with let-7e, mir-155, as-let-7e, as-miR-155, or combinations of these. As shown in (A), TNF-a, IL-6, IL-17, IP-10, MCP-1, MIP-1a, and PGE2 were measured at 12 and 24 hr after LPS stimulation (n = 3; ± SEM) *p < 0.05, **p < 0.01, and ***p < 0.001 compared to control-transfected cells stimulated with LPS for the same time period. Results are representative of three independent experiments. As shown in (B), thioglycollate-elicited macrophages from Akt1 +/+ and Akt1 À/À mice were stimulated with LPS for 24 hr; TNF-a, IL-6, IL-17, IP-10, MCP-1, MIP-1a, PGE2, and NO were measured in the culture supernatants (n = 3; ± SEM) **p < 0.01 and ***p < 0.001 compared to Akt1 +/+ cells. Results are representative of five independent experiments for TNF-a and IL-6 and two independent experiments for IL-17, IP-10, MCP-1, MIP-1a, PGE2, and NO.
Immunity
Akt1 Regulates Endotoxin Tolerance via miRNAs and reduced amounts of SOCS1, we wanted to confirm that the Akt1 phenotype was mediated by these miRNAs. To this end, we transfected let-7e and as-miR155 or SCR-miRNA in primary BMDMs from Akt1 À/À mice and determined expression of TLR4 and SOCS1 upon LPS stimulation. The results showed that transfection of let-7e in Akt1 À/À macrophages restored their ability to suppress TLR4 expression in response to LPS ( Figures  6A and 6B) . Similarly, transfection of as-miR-155 in Akt1 À/À macrophages resulted in comparable levels of SOCS1 to those observed in Akt1 +/+ mice ( Figures 6C and 6D ).
To confirm that the LPS hyperresponsiveness observed in Akt1 À/À macrophages was due to altered expression of let-7e
and miR-155, we simultaneously transfected Akt1 À/À BMDMs with let-7e and as-miR-155 or SCR-miRNA and stimulated them with LPS for 12 or 24 hr. TNF-a and IL-6 were measured in the culture supernatants and showed that transfection of let7e and as-miR-155 restored the response of Akt1 À/À macrophages to LPS ( Figures 6E and 6F ), suggesting that Akt1 controls the responsiveness of macrophages to LPS via let-7e and miR-155. As-miR-155 effectively suppressed miR-155 in BMDMs (data not shown). 
Ablation of Akt1 Inhibits the Induction of Endotoxin Tolerance
Given that the increased response of Akt1 À/À macrophages to LPS resulting from reduced induction of SOCS1 and absence of TLR4 suppression are hallmark events for the development of endotoxin tolerance, we investigated whether ablation of Akt1 interferes with the development of endotoxin tolerance. When macrophages are exposed to an initial LPS stimulus, they initiate tolerance mechanisms and upon restimulation, they fail to effectively produce proinflammatory cytokines. BMDMs were, therefore, tolerized with an initial LPS treatment for 6 hr, culture media were changed, and cells were exposed to a second LPS stimulus for different time periods. The results showed that whereas Akt1 +/+ macrophages became tolerant to subsequent LPS stimulation and produced low amounts of proinflammatory cytokines, Akt1 À/À macrophages did not and continued to produce proinflammatory cytokines in response to the second LPS stimulus ( Figures 7A and  7B ). To evaluate the contribution of let-7e and miR-155 in the abrogation of LPS-tolerance observed in Akt1 À/À macrophages, we transfected Akt1 À/À BMDMs with let-7e and as-miR-155 or SCR-miRNA, tolerized them with a first LPS stimulus, and restimulated them with LPS for different time periods. Proinflammatory cytokines were measured in culture supernatants and showed that introduction of let-7e and suppression of miR-155 in Akt1 À/À macrophages restored tolerance to LPS ( Figures 7A   and 7B ). LPS-induced cytokine production in culture is the result of continuous stimulation because LPS remains active throughout the stimulation period; thus, the differences in cytokine production observed in LPS-treated Akt1 À/À macrophages in culture are, at least in part due to the defects in negative regulatory mechanisms. In vivo, LPS is rapidly neutralized by serum lipoproteins (Flegel et al., 1993; Freudenberg et al., 1980) , allowing us to address the role of Akt1 at the early stages of macrophage activation. Intraperitoneal (i.p.) inoculation of a cohort of 12 wildtype and 9 Akt1 À/À mice with 1.5 mg LPS per 25 g of body weight, being the minimal lethal dose as determined by titration experiments (see Experimental Procedures), revealed no significant differences in LPS sensitivity between the two genotypes ( Figure 7C ). Measuring TNF-a and IL-6 in the serum revealed no statistically significant differences between the two groups ( Figure 7D ). This result suggested that Akt1 may be redundant during the initial phase of macrophage activation but is required at later stages for the induction of miRNAs and development of endotoxin tolerance. Earlier studies have shown that overexpression of Akt1 suppresses ERK1, ERK2, and NF-kB activation in LPS-stimulated macrophages. We, thus, treated Akt1 À/À and Akt1 +/+ macrophages with LPS and measured ERK1 and ERK2 phosphorylation and IkBa degradation. LPS-activated Akt1 À/À macrophages exhibited increased ERK1/2 activation ( Figure S5 ) but no change in IkBa degradation ( Figure S6 ), suggesting that Akt1 plays an inhibitory role in early TLR4 signals, but its ablation is not sufficient to suppress proinflammatory cytokine production at the early stages of endotoxemia.
To determine whether Akt1 is essential for the development of endotoxin tolerance in mice, we inoculated another cohort of 9 Akt1 +/+ and 11 Akt1 À/À mice with a sublethal dose of LPS (500 mg/25 g body weight) i.p. and 24 hr later, with a lethal dose of LPS (1.5 mg/25 g body weight), also i.p. The results showed a significant delay in endotoxin-induced mortality in wild-type but not in Akt1 À/À mice ( Figure 7E ) accompanied by increased TNF-a and IL-6 in the serum of Akt1 À/À mice (Figure 7F) , suggesting that the ablation of Akt1 inhibits the induction of endotoxin tolerance in vivo.
To address the involvement of let-7e and miR-155 in endotoxin tolerance in vivo, we treated Akt1 +/+ and Akt1 À/À mice with a tolerogenic sublethal dose of LPS. The expression of let-7e, miR-155, and their pri-miRNA precursors was measured in macrophages, which were isolated by cell sorting 6 hr later from the spleens of these animals. let-7e was induced in Akt1
but not in Akt1 À/À macrophages, and miR-155 was induced in Akt1 +/+ and super-induced in Akt1 À/À macrophages ( Figure 7G ).
Expression of TLR4 was measured in macrophages from the same mice at both the mRNA and protein levels. TLR4 was downregulated in Akt1 +/+ but not in Akt1 À/À macrophages (Figures 7H and 7I) . Finally, the expression of SOCS1 at the mRNA and protein levels was measured in macrophages and spleen lysates, respectively. SOCS1 was induced to express higher in Akt1 +/+ than in Akt1 À/À macrophages ( Figures 7H and 7I ). These results confirmed that let7e, miR-155, and their targets are differentially regulated in vivo, in Akt1 +/+ and Akt1 À/À mice inoculated with a sublethal, tolerogenic dose of LPS. To confirm that let7e and miR-155 were responsible for Akt1-dependent endotoxin tolerance in vivo, we first depleted C57BL/ 6 mice of macrophages, by using liposome-encapsulated clodronate. The macrophage-depleted mice were reconstituted with Akt1 +/+ or Akt1 À/À BMDMs, transfected with let-7e and asmiR-155, or SCR-miRNA. To monitor the reconstitution of macrophage-depleted animals, we transfected donor BMDMs with FAM-labeled SCR-RNA, which rendered them fluorescent (see Figure S7) . Experimental mice were inoculated with a sublethal dose of LPS and inoculated 24 hr later with the LD50 dose, as determined by titration experiments (see Supplemental Experimental Procedures). The results showed that mice reconstituted with Akt1 À/À macrophages, or Akt1 À/À macrophages transfected with SCR-miRNA, were not tolerant to the second dose of LPS. However, mice reconstituted with BMDMs transfected with let-7e and as-miR-155 became tolerant, as indicated by their resistance to LPS determined by survival and cytokine production ( Figure S8) . We, therefore, conclude that Akt1 contributes to endotoxin tolerance in vivo by regulating the expression of let-7e and miR-155.
DISCUSSION
LPS stimulation of macrophages results in differential expression of miRNAs that contribute to the inflammatory response. Evidence presented here confirmed these observations and identified miRNAs that are controlled by Akt1. Moreover, we provide evidence associating miRNA expression with the regulation of molecules controlling macrophage sensitivity and tolerance to LPS. The present study identified let-7e and miR-181c to be positively regulated by Akt1 in LPS-activated macrophages, whereas miR-125b and miR-155 to be negatively regulated. Earlier studies had shown that let-7i, an isoform of let-7e, targets TLR4 in human cholangiocytes (Chen et al., 2007) , that miR-155 targets TNF-a, PU.1, SHIP1, and SOCS1 (Lu et al., 2009; Tili et al., 2007; Vigorito et al., 2007) , and that miR-125b targets TNF-a . Our in silico analysis showed that let-7e targets TLR4, that miR-155 targets SOCS1, and that miR-181c targets TNFSF11 (RANKL). MiR-181c is suppressed in leukemia cells (Yu et al., 2006) and in response to TPA in HL-60 cells (Chen et al., 2008) . The present work showed that miR-181c is induced by LPS, and such an induction may contribute to LPS-induced RANKL suppression (Maruyama et al., 2006) . Akt1 deletion resulted in inhibition of miR-181c induction, whereas RANKL was further inhibited in the absence of Akt1 (data not shown), suggesting that Akt1 controls RANKL through a more complex mechanism. LPS also suppressed miR-125b in an Akt1-dependent manner, whereas expression of the miR-125b target TNFa was augmented in Akt1 À/À macrophages. It is likely that the higher expression of miR-125b in Akt1 À/À macrophages cannot effectively suppress TNF-a and that other targets of the same miRNA may positively contribute in LPS signaling. Our studies focused on let-7e and miR-155 because they control genes that regulate macrophage responsiveness to LPS. Indeed, Akt1 ablation resulted in hyperresponsiveness to LPS. Previous studies have shown that PI-3K and its downstream target Akt are activated by TLR4 signals and that they may function in a feedback loop that inhibits the response to both the primary and secondary exposure to TLR4 activators (Fukao and Koyasu, 2003) . These inhibitory effects may be mediated by PI-3K targets other than Akt, or by Akt. We, therefore, examined the phenotypic consequences of a single Akt isoform ablation. Akt1 is only partly redundant during the early stages of macrophage activation because its deletion does not affect primary endotoxemia and NF-kB activation, but it augments ERK1 and ERK2 activation during the initial response to LPS, although it appears to be essential at later stages for the development of endotoxin tolerance. As a result, ablation of Akt1, À/À mice were transfected with SCR-miRNA or with let-7e and as-miR-155, stimulated with LPS for 6 hr, and restimulated with LPS.
(A) TNF-a and (B) IL-6 was measured in the culture supernatant (n = 3; ± SEM); **p < 0.01 and ***p < 0.001 compared to Akt1 À/À macrophages transfected with let7e and as-miR-155 and compared to Akt1 +/+ macrophages. Results are representative of three independent experiments.
(C) Akt1 À/À (n = 9) and Akt1 +/+ (n = 12) mice were treated once with 1.5 mg/25 gr LPS, and survival was monitored.
(D) TNF-a and IL-6 were measured in the serum 2 and 4 hr after LPS administration, respectively. Results represent measurements of six mice per group (±SEM).
(E) Akt1 À/À (n = 11) and Akt1 +/+ (n = 9) mice were treated with 500 mg/25 gr for 24 hr and then restimulated with LPS at 1.5 mg/25 gr. Survival of animals was monitored.
(F) Serum TNF-a and IL-6 was measured 1 and 4 hr after LPS restimulation, respectively. Results represent measurements from five mice per group (±SEM); *p < 0.05 and **p < 0.01. (G) F4/80 + macrophages were isolated from the spleen of LPS-injected (500 mg/25 g) Akt1 +/+ and Akt1 À/À mice 6 hr after injection and let-7e, miR-155, pri-let-7e, and pri-miR-155 were measured (n = 3; ± SEM). Results are representative of three mice per strain.
similar to the inhibition of PI-3K, gave rise to a proinflammatory phenotype. This suggests that the proinflammatory phenotype of PI-3K inhibition is, at least partly, due to Akt1 because despite the fact that Akt2 and Akt3 are also regulated by PI-3K, they are functionally inert with regard to negative feedback signals in macrophages. All Akt isoforms are expressed in macrophages with Akt1 and Akt2 being expressed at higher amounts than Akt3 (Shiratsuchi and Basson, 2007) , but hyperresponsiveness to LPS appeared to be a specific attribute of Akt1 À/À macrophages because the ablation of Akt2 was associated with hyporesponsiveness to the same stimulus both in culture and in vivo (data not shown).
The unique role of Akt1 is also supported by earlier studies that had shown that Akt1 À/À Apoe À/À mice produce large amounts of proinflammatory mediators that promote the development of atherosclerosis (Fernandez-Hernando et al., 2007) . However, this study suggested that the proatherogenic phenotype promoted by Akt1 ablation primarily depends on endothelial cell dysfunction and production of proinflammatory mediators. Here, we showed that macrophages were also affected by Akt1 ablation and contribute to a proinflammatory phenotype. Moreover, we demonstrate that miRNAs mediated the augmented response to TLR4 signals and genetic manipulation of these miRNAs restored the Akt1 À/À proinflammatory phenotype. Whether the proinflammatory phenotype in endothelial cells depends on the same miRNAs remains to be determined.
Studies in Mir155 À/À mice have shown that miR-155 suppresses TAK1-associated binding protein 2 (TAB2), a key molecule in the TLR4 signaling cascade, and thus inhibits TLR4 signals in dendritic cells (Ceppi et al., 2009) and that inhibition of miR-155 in BMDMs augments the expression of several proinflammatory mediators (Ruggiero et al., 2009) , supporting an anti-inflammatory role for miR-155. In contrast, another report showed that miR-155 suppresses the phosphatase SHIP1 (O'Connell et al., 2009 ) and we showed that it suppressed SOCS1, both negative regulators of macrophage activation. Moreover, in vivo inhibition of miR-155 in mice suppressed G-CSF production upon LPS treatment (Worm et al., 2009) , also supporting a proinflammatory role of miR-155. Given that miRNAs have multiple targets and some of their targets are also transcriptional regulators, it is likely that suppressing a single miRNA, either in germline or with as-miRNAs, will result in a different phenotype from that obtained when expression of multiple miRNAs is affected. Cross-regulation between signaling proteins and miRNAs is highlighted by the fact that miR-155 suppressed SHIP augmenting Akt kinase activity (O'Connell et al., 2009) , whereas Akt transcriptionally suppressed miR-155, indicating that miRNAs and signaling proteins participate in regulatory loops controlling cellular responses.
In conclusion, our data suggest that Akt1 is a key molecule for the regulation of LPS responsiveness and tolerance by regulating miRNAs that control TLR4 and fine-tune SOCS1 expression. Thus, systemic inhibition of Akt1, drugs for which are currently under development, may contribute to a proinflammatory phenotype. Understanding the mechanism through which PI-3K and Akt1 modulates the inflammatory response will allow us to selectively target molecules controlling PI-3K-Akt1 signals to positively or negatively regulate the inflammatory response. Given the importance of Akt and miRNAs in cancer and other human diseases, these findings may have translational implications.
EXPERIMENTAL PROCEDURES Animals C57BL/6 mice were purchased from the Hellenic Pasteur Institute (Athens, Greece). Akt1 À/À and Akt1 +/+ mice (Mao et al., 2007; Maroulakou et al., 2007) were housed at the University of Crete School of Medicine, Greece. All procedures described below were approved by the Animal Care Committee of the University of Crete School of Medicine, Heraklion, Crete, Greece, by the Veterinary Department of the Heraklion Prefecture, Heraklion, Crete, Greece, and by the DLAM at TUFTS-Medical Center, Boston, USA.
Cell Culture
The murine macrophage cell line RAW264.7 and primary murine peritoneal macrophages were cultured as previously described (Arranz et al., 2008) . E.coli-derived LPS (1 mg/ml) (O111:B4; catalog no. L2630; Sigma-Aldrich) was used as described in the Results.
Isolation of Total RNA and Real-Time RT-PCR Total-cellular RNA was isolated with TRIzol Reagent (Invitrogen). cDNA was prepared by reverse transcription (Thermoscript RT; Invitrogen) and amplified by PCR with the following primers:
Detection of TLR4 mRNA was performed as previously described (Medvedev et al., 2000; Nomura et al., 2000; Tsatsanis et al., 2006) . Amplification was performed as in an ABI PRISM 7000 Real-Time PCR engine. The amplification efficiency of the TLR4 and SOCS1 was the same as the one of b-actin as indicated by the standard curves of amplification, allowing us to use the formula: fold difference = 2
, where Ct is the cycle threshold. Reactions were performed in triplicate for statistical evaluation.
Flow Cytometry Analysis and Cell Sorting
Cells were washed twice with PBS containing 1% BSA. Nonspecific binding was blocked with Fc-block (BD Biosciences). Washed cells were resuspended in a 1:200 dilution of PE-conjugated anti-mouse TLR4 antibody (clone MTS510; e-Bioscience) or the anti-mouse pan-macrophage marker F4/80 (Clone BM8-eBioscience). Stained cells were washed twice with PBS containing 1% BSA, and they were analyzed by flow cytometry (FACSCalibur, BD Biosciences, and CyAn, DAKO). Sorting of F4/80 stained macrophages was performed in a MoFlo cell sorter (DAKO).
LPS-Induced Endotoxin Shock and ELISA Assays
For titration of the dose of LPS, mice received i.p. injections of 1, 1.5, or 2 mg of LPS per 25 g of body weight. LPS was dissolved prior to injection in phosphatebuffered saline at a concentration of 10 mg/ml. Injected animals were monitored for a 24 hr period, and they were sacrificed when moribund. The results showed that the minimal lethal dose of LPS was 1.5 mg (data not shown), which was used in the subsequent experiments. Cytokine concentration in serum was determined by enzyme-linked immunoabsorbent assay (ELISA) at the indicated time points. ELISA assays measuring cytokine concentration in serum samples and in culture supernatants were carried out with ELISA kits (R&D Systems) or a bead-based ELISA assay (Lincoplex-Millipore).
MicroRNA and pri-miRNA Expression
The expression profile of 365 microRNAs was addressed with TaqMan micro-RNA microarrays as previously described (Thum et al., 2007) for pri-miR-125b: forward: 5 0 -AGCAAGGGTTTCACCATGAC-3 0 and reverse: 5 0 -CACACCCAAAGCGATGTTTA-3 0 ; 18S was used as an internal control.
Potential miRNA targets were identified with the miRBase (http://microrna. sanger.ac.uk/), PicTar (http://pictar.bio.nyu.edu/), and TargetScan version 4.0 (http://www.targetscan.org/index.html) search engines. For optimizing the accuracy of prediction, a given target should be predicted by a minimum of two out of three programs and the targeted sequence should be conserved among species.
Immunoblot Analysis Detection of SOCS1 protein was performed by immunoblot analysis as previously described (Dumitru et al., 2000) . SOCS1 was detected with a polyclonal SOCS1 antibody (ZYMED-Invitrogen), and protein loading was determined with a monoclonal tubulin antibody (SIGMA). Proteins were visualized with the ECL Western blotting kit (ECL Amersham Biosciences), and blots were exposed to Kodak X-Omat AR films.
Transfection of myrAkt1, miRNAs, and Antisense miRNAs BMDMs were differentiated as previously described (Dumitru et al., 2000) . After differentiation, cells were seeded in six-well plates and infected with a retrovirus expressing myristyolated Akt1 and GFP under the control of two distinct CMV promoters. Seventy-two hours later, almost all cells (>90%) expressed Akt1 and GFP as determined by fluorescence microscopy and FACS analysis. Raw264.7 cells were infected with the myr-Akt1-GFP retrovirus with the same procedure. In parallel experiments, a plasmid expressing Akt1 and GFP under CMV promoters was transfected in Raw264.7 cells with lipofectamine 2000 (Invitrogen) and GFP expressing cells were sorted and analyzed (Dako cytomation sorter). For miRNA tranfection studies, Raw264.7 cells were seeded in six-well plates and were transfected with 50 nM of miRNAs let-7e and miR-155, with antisense miRNAs as-let-7e and as-miR-155 (Ambion), or with a Scrambled miRNA (SCR-miRNA, Ambion Cat#AM17110), through use of the transfection agent siPORT NeoFX. RNA was extracted at different time points (0, 6, 12, 24 , and 48 hr) after microRNA transfection, and real-time PCR analysis was performed as described above.
Luciferase Assays
The 3 0 UTR of murine TLR4 and murine SOCS1 was cloned in the pMIR-REPORT-luciferase vector (Ambion) as described in Supplemental Experimental Procedures. Constructs were transfected in Raw264.7 and luciferase activity was measured with the Luciferase Reporter Assay System (Promega).
Statistical Analysis
All values are expressed as the mean ± SEM of data obtained from at least three experiments. Comparison between groups was made with the Student's t test and ANOVA test. Log Rank analysis was used for survival experiments. p < 0.05 was the significance level.
ACCESSION NUMBERS
The results of the miRNA arrays are available in the Gene Expression Omnibus (GEO) database (http://www.ncbi.nlm.nih.gov/geo/). The accession number is GSE17421.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and eight figures and can be found with this article online at http://www.cell.com/ immunity/supplemental/S1074-7613(09)00328-8.
